Inveready successfully closes Inveready Innvierte Biotech II, its second life sciences fund — Inveready

Inveready announces the successful closure of its life sciences fund Inveready Innvierte Biotech II. This is the second fund the firm has closed within this investment strategy, following the success of the first fund in 2020, again achieving a return of more than 4x the initial investment.